Cell Hybridization. The cell hybridization technique for the production of hybridomas secreting alloantibodies has been described in detail elsewhere (8, 9) . In the present case, four female AK_R mice were immunized intravenously with a mixture of 2 × 10 v spleen and thymus cells of male C57BL/6 mice. After 3 wk the mice received an additional injection of 3 × 107 spleen cells and 3 × 107 thymocytes. 3 d later the spleen cells were hybridized with the myeloma P3-NS-I-Ag4 (a gift of Dr. C. Milstein, Cambridge University) with polyethylene glycol, mol wt 4,000. The fusion mixture was distributed at a density of 5 × 105 cells per well into 624 cups of Costar 3524 multiwell plates (Costar, Data Packaging, Cambridge, Mass.). Growth of hybrid cells was observed in 308 wells.
Culture supernates were tested for alloantibody activity in a microcytotoxicity assay (9) with C57BL/6 spleen cells as target cells.
Cloning of hybridoma cells from wells displaying cytotoxic activity was performed by the limiting dilution technique (10) . For further analysis, either culture supernates of cloned cells were used, or high titered ascites fluids were obtained by intraperitoneal injection of hybridoma cells into either (AKR × DBA/2)F1 or NMRI nu/nu mice which 2 d previously had received 0.5 ml mineral oil intraperitoneally (11) .
Serological Methods. Serological analysis of monoelonal antibodies was performed utilizing the microeytotoxicity assay (9) as well as the chromium release assay (3) . For indirect immunofluorescence, cells were first incubated with monoclonal antibodies for 30 min at 4°C and subsequently, after washing, with fluorescein-conjugated rabbit anti-mouse Ig (Behringwerke, Marburg/Lahn, Federal Republic of Germany) for another 30 min at 4°C. Fluorescence was evaluated with a fluorescence microscope (Leitz, Wetzlar, Federal Republic of Germany) and with a fluorescence-activated cell sorter (FACS I, Becton, Dickinson FACS Systems, Mountain View, Calif.). Removal of B lymphocytes was performed by either nylon wool fractionation (12) or by use of anti-mouse-Ig-coated plastic dishes (13) .
Results
The spleen cells of two AKR mice immune to C57BL/6 lymphocytes were hybridized with the myeloma P3-NS-1-Ag4. Of 624 wells, each seeded with 5 × l0 s cells, 308 showed growth, and two wells, numbers B 16-146 and B 16-167, contained cytotoxic antibody for C57BL/6 spleen cells. Hybridoma cells from these wells were cloned by the limiting dilution technique. Because all subclones isolated were antibody positive, the original wells contained most likely single, stable clones. Both hybridomas were adapted to growth in ascitic form in either (AKR × DBA/2)F1 or NMRI nu/nu mice which had received 0.5 ml mineral oil 2 d previously. Precipitation of ascitic fluid by ammonium sulfate yielded 14 mg/ml of immunoglobulin for B16-146 and 6.5 mg/ml for B16-167. Fig. 1 shows the cytotoxicity titers of ascites and culture supernates. Accordingly, ascites fluids (Fig. 1A) contain 100-to 1,000-fold higher antibody concentrations than culture supernates (Fig. 1 B) . Culture supernates of both hybridomas contain immunoglobulins consisting of #-heavy and kappa light chains, as determined by reaction with class specific anti-immunoglobulin conjugated with alkaline phosphatase, according to a technique developed by J. F. Kearney (personal communication).
Mapping Studies and Strain Distribution. Because, as will be shown below, the two monoclonal antibodies react with T-cell antigens governed by the Qa/Tla region, these antigens have been designated Qat-4 and Qat-5. In Table I , the reactivity patterns obtained with some inbred strains are listed. It can be seen that monoclonal antibodies B16-146 (anti-Qat-4) and B16-167 (anti-Qat-5) react with splenocytes of C57BL/6 and B10 mice but fail to lyse cells from congenic B10.BR mice. These data indicate linkage of the respective genes to the MHC. Typing of intra H-2 recombinant strains showed strongly positive reactions for strains carrying the H-2D b allele, e.g., During the course of the mapping studies it was surprising to find that neither A/ Boy nor A.Tla b strains reacted with anti-Qat-4 and anti-Qat-5 although both A/J and C57BL/6 were positive. C57BL/6 has been thought to have provided the Qa/Tla region of the A-tla b recombinant. Possible explanations for this observation will be discussed below. Table II summarizes the results of an extensive strain distribution analysis. Two cytotoxicity procedures were used in parallel. In the first, cytolysis was scored by trypan blue exclusion, and in the other by Cr 51 release. In most cases strains typing positively for anti-Qat-4 are also positive for anti-Qat-5, exceptions were strains A/ HeJ and A/J, which reacted with the former, but not the latter antibody. In view of the generally much weaker reactions of the anti-Qat-5 antibody it is possible that the assay failed to reveal a weak cross-reactivity. No strain has been found which is positive for Qat-5 and negative for Qat-4.
Selective Reactivity of Monoclonal Anti-Qat-4 and Anti-Qat-5 with Peripheral T-Cell Populations.
In view of the observations that anti-Qat-4 and anti-Qat-5 lyse only a proportion of spleen cells (50 and 30%, respectively; see Fig. 1 ) and because of linkage of the respective genes to the Q.a region, T cells were strongly implicated. An analysis was undertaken to verify whether the respective antigens were expressed on either T cells or B cells, or both. The results have confirmed the selective expression on T cells. As summarized in Table III , thymocytes and anti-Thy-l.2-treated spleen cells (>95% Ia +) did not react with either antibody, whereas nylon-purified T cells (12) and antiIg-treated spleen cells (13) (>90% Thy-l.2 +) reacted strongly. Anti-Q.at-5 killed consistently 35% of peripheral T cells, and anti-Qat-4 was cytolytic for 75% of T cells, with a titer of 10 -6. Thus, both antibodies define two T-cell-associated differentiation antigens which are expressed by distinct subpopulations within peripheral T cells. (13) . B cells were obtained by treatment of spleen cells with antibody 6/68 (anti-Thy-1.2) plus complement. The average percent lysis determined by several independent microcytotoxicity assays is presented.
Among other tissues, brain, liver, kidney, and erythrocytes were found to be negative as indicated by their inability to absorb the anti-Qat antibodies (data not shown).
Reactivity with Cells from Nude Mice.
In the course of an analysis of spleen cells of C57BL/6 nu/nu mice as a source of B lymphocytes, it has been found that anti-Qat-4 antibody (but not anti-Qat-5) reacted with a small proportion of cells (see Fig. 3 A) . After removal of immunoglobulin-bearing cells (13) from nude spleen the anti-Qat-4-positive cells could be shown to belong to the pool of Ig-negative cells some of which were also Thy-l.2 positive and may therefore constitute T cells (see Fig. 3B ). The failure of anti-Qat-5 to react with C57BL/6 nu/nu spleen cells may again be explained on the basis of the generally weaker cytolytic titer of this antibody as compared to anti-Qat-4. Even this powerful antibody had a titer of only 10 -3 on C57BL/6 nu/nu target cells, which may point to a low epitope density of Q.at-4 determinants on nude spleen cells, as opposed to normal T cells. 
Fluorescence Profile of T Cells Reactive with Anti-Qat-4 and Anti-Qat-5.
Additional information on the reactivity pattern of anti-Qat-4 and anti-Qat-5 was obtained through analysis by a fluorescence-activated cell sorter (FACS). B cells were depleted from C57BL/6 lymph node cells by adherence to rabbit anti-mouse-Ig-coated dishes (13) , and the resulting purified T cells were reacted with ascites fluids at a 1:50 dilution, and after washing, with fluorescein-conjugated rabbit anti-mouse Ig. As a negative control a 1:50 dilution of ascites fluid of BALB/c mice bearing the plasmacytoma P3-X63-Ag8 was used, although positive controls consisted of monoclonal anti-Thy-l.2 of clone 5/68, which like anti-Qat-4 and anti-Qat-5 belongs to the kappa/# class (10). Another positive control was culture supernate from monoclonal anti-Ly-2.2 antibody hybridoma 19/178 (kappa, IgG2A) (U. H/immerling, unpublished observations). The fluorescence profiles of Qat-4 obtained with the FACS (see Fig. 4 ) display a distinct shoulder which comprised 68.5% of peripheral T cells. For Qat-5 the number of positive cells was calculated to be 29.2% above the background control with P3-X63-Ag8 antibody. However, no distinct peak or shoulder was found (see Fig. 4A ). The cells displaying a continuum of weakly positive to negative, made the exact determination of positive cells somewhat ambiguous. However, because cytotoxicity analysis and FACS analysis were in close agreement for practical purposes, a distribution of 70% for Qat-4 and 30% of Qat-5 within the peripheral T population may be sufficient. For comparison, the fluorescence profiles of the same T cells stained with monoclonal anti-Ly-2.2 and anti-Thy-l.2 are also presented (see Fig. 4B ). Staining with anti-Ly-2.2 results in a sharp peak comprising T cells, whereas staining with anti-Thy-l.2 covers a wide range from dim to very bright cells. Although these data do not allow firm calculations of the number of antigenic determinants per cell, it can be estimated that on the average, T cells express several times more Thy-l.2 antigens than Qat-4 and Qat-5 determinants.
Discussion
The availability of techniques to produce monoclonal antibodies against specific alloantigenic determinants provided us with the opportunity to search for antibodies against new cell surface structures in immunizations between noncongenic partner strains such as AKR anti-C57BL/6. Of the several monoclonal antibodies produced in this immunization, two, B16-146 and B16-167, appear to recognize new antigenic determinants governed by the Qa region. Because these new antigens are selectively expressed on subpopulations of peripheral T lymphocytes, they were provisionally designated Qat-4 and Qat-5, respectively. The loci (or locus) governing the expression of these antigenic determinants were located on the basis of serological studies of H-2 and Tla region recombinants and congenic strains. The more salient features of this analysis are given below:
(a) The strain distribution of Qat-4 and Qat-5 according to direct cytotoxicity assays on nylon column purified cells and lymph node lymphocytes indicates that Qat-4 and Qat-5 expression are governed by genetic loci on chromosome 17 which are different from H-2, la, and Tla.
(b) Reactivity of these antisera against B6.K2 cells and not B6.K1 cells indicates that the locus or loci governing Qat-4 and Qat-5 are near Qa-2 and Qa-3 but not identical to these loci on the basis of tissue distributions (see below) and on the basis of strain distributions (Table II) .
(c) The expression of Qat-4 and Qat-5 seems to depend on the expression of Qa-2. All strains which are Qa-2-are also Qat-4-and Qat-5-, whereas Qa-2 + strains can either be Qat (Table I) .
Studies on the tissue distribution show clearly that among lymphocytes, Qat-4 and Qat-5 antigens are restricted to peripheral T lymphocytes on which they occur in a lower density than Thy-1 determinants, as indicated by fluorescence studies. They are absent from thymocytes, suggesting that immature, Qat-4 negative thymocytes differentiate into Qat-4 positive T cells. However, Qat-4 antigen is also present, albeit in a low density, on Ig-negative lymphocytes from nude mice, indicating that these cells can acquire a T-cell differentiation marker in the absence of a thymic environment. Similar observations have been reported by Loor and Roelants (15) with regard to the expression of Thy-1.2 on spleen cells in nude mice.
It is not clear whether Qat-4 and Qat-5 antigens are identical with or different from any of the known antigens specified by the Tla region. Of these, TL, Qa-1, and Qa-2 can be excluded because these antigens are expressed on thymocytes which lack Qat-4 and Qat-5. In contrast, Qa-3, Qat-4, and Qat-5 antigens appear to be similar with regard to their restricted expression on peripheral T cells. However, the strain distributions of known Qa-3 alleles (14) and of Qat-4 and Qat-5 are not completely identical. Qa-3 can be found on BALB/cJ cells (5) which are unreactive with our monoclonal antibodies. Qa antigens defined with conventional antisera, may still represent complex systems and may include Qat-4 and Qat-5 antigens. Obviously, highly specific monoclonal antibodies to Qa antigens and TL being developed in our laboratories will be more suitable reagents for the definition of antigenic determinants encoded by the Tla region.
The observation that the two monoclonal antibodies react with a different percentage of T lymphocytes (70 and 30%, respectively) does not necessarily distinguish the Qat-4 and Qat-5 antigens as two different antigens. They may represent two different ar~tigenic determinants on the same molecule. However, if this were the case then one has to assume that the two determinants are located far apart on the Qat molecule because the binding of radioiodinated anti-Qat-5 to T cells could only be inhibited by preincubation with cold anti-Qat-5 but not by cold anti-Qat-4 (unpublished data).
Depletion of lymphocyte subpopulations with anti-Qat sera should reveal if these antibodies can be used for the definition of functional T-cell populations. Preliminary studies indicate that treatment of T helper cells with either anti-Qat-4 or anti-Qat-5 and complement had no effect on helper activity for antibody formation, whereas with anti-Qat-5 an increase in helper activity was frequently observed, suggesting the removal of regulatory T cells by this antibody.
Summary
Two new lymphocyte antigens, provisionally designated Qat-4 and Qat-5 have been identified with two different hybridoma-derived, monoclonal AKR anti-C57BL/6 antibodies. These antigens are governed by genes located to the right (distal) end of the H-2 complex, within the Qa-2,3 region. Qat-4 and Qat-5 antigens which do not seem to be identical with Qa-2,3 or TL antigens are absent from Ig + lymphocytes and thymocytes. They are only present on a fraction of peripheral T cells. Thus, Qat-4 is expressed on 70%, and Qat-5 on 30% of splenic and lymph node T cells, Qat-4 is also found on the majority of Ig-cells from athymic nude mice. These findings illustrate the complexity of the chromosome segment between the H-2D and Tla loci and they emphasize the role of major histocompatibility complexassociated genes for the differentiation of T ceils into different subpopulations with possibly distinct immunologic functions.
